Sectra´s cardiology products receive FDA clearance for the US market
Sectra´s cardiology products receive FDA clearance for the US market Sectra, the Swedish IT and medical technology company, has received FDA approval for its analysis package for cardiovascular imaging. The application provides physicians with analysis functions for quantifying arterial stenosis and overall heart function, including tools for Quantitative Coronary Analysis (QCA) and Left Ventricle Analysis (LVA). The new cardiology analysis package joins a family of focused clinical solutions, extending Sectra's core PACS offering and meeting the specific needs of healthcare specialists. "This approval strengthens our position not only as a PACS provider for radiology but also as a provider of clinical applications to meet the specialized needs of today's physicians", says Hans Lugnegård, manager for Sectra Clinical Applications program. With Sectra's cardiology application physicians get access to specific clinical tools designed to support the diagnostic process, increase the reproducibility and improve workflow efficiency. About Sectra Sectra, selected as the recipient of the 2004 Frost & Sullivan Medical Imaging Company of the Year Award, is one of today's major diagnostic imaging providers with more than 500 installations worldwide. Sectra's core business is to deliver top-of-the-line, high-availability, robust enterprise diagnostic imaging for 24/7 operation. In Scandinavia Sectra is the market leader with more than 50 percent of all film-free installations. The company also has a large number of systems installed in most major countries in Europe, the Far East and North America, in co-operation with partners. For more information, visit www.sectra.com. For further information, please contact: Dr. Torbjörn Kronander, President Sectra Imtec AB +46 705 23 52 27 Dr. Jan-Olof Brüer, President and CEO Sectra AB +46 13 23 52 09, job@sectra.se Visit our website http://www.sectra.com Sectra's operations Sectra has its roots in Linköping Institute of Technology and is one of Sweden's fastest growing high-tech companies in IT. Since the mid-1980s, Sectra has successfully conducted development and sales of advanced IT and medical technology products. Today, the business includes products in medical systems, secure communication systems and wireless information systems. Sectra's medical business is conducted in Sectra Imtec AB, which is a wholly owned subsidiary of Sectra AB. Internationally, Sectra PACS is marketed and sold through different partners. Business is conducted in eight countries with a total of more than 300 employees. Sales for the fiscal year 2002/03 reached SEK 503 million. Since March 1999, Sectra's shares have been quoted on the O list of the Stockholm Exchange. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/05/07/20040505BIT20910/wkr0004.pdf